State of CNS Open Data 2026 Q1: Spatial Multi-Omics Expansion & Blood Biomarker Standardization
Cross-repository quantitative synthesis across OpenNeuro, DANDI, Allen Brain Map, Agora, and PubMed/Europe PMC
During the first quarter of 2026, open-access central nervous system (CNS) repositories experienced a decisive structural shift toward multimodal integration. Rather than isolated single-modality releases, newly indexed datasets increasingly pair high-resolution cellular atlases (snRNA-seq, MERFISH) with longitudinal clinical fluid biomarkers (plasma p-tau217, NfL) and standardized neuroimaging (BIDS 7T MRI and synaptic SV2A PET). This report synthesizes quantitative repository metrics from the CNS Open Data Portal alongside critical methodological trends shaping neurodegenerative drug discovery.
Surge in AnnData (.h5ad) & MERFISH spatial transcriptomics deposits across AD and ALS cohorts
Over 90% of newly ingested neuroimaging and electrophysiology datasets pass automated schema validation
CC0 and CC-BY-4.0 dominate public archives, accelerating foundation model pre-training
Live Portal Repository & Disease Breakdown
Resources by Disease Domain
Resources by Primary Repository
1. Alzheimer's Disease: Plasma p-tau217 & Amyloid-Targeting Therapy Monitoring
2. Parkinson's Disease: Alpha-Synuclein Seed Amplification (SAA) & Subthalamic NWB Recordings
3. ALS & Multiple Sclerosis: Cryptic Exon Biomarkers, Smoldering Neuroinflammation & 7T MRI
Future Outlook
Looking ahead to Q2 2026, we anticipate increased release of spatial proteomics alongside single-cell chromatin accessibility (snATAC-seq) atlases, as well as broader adoption of federated learning protocols for cross-biobank clinical trial emulation.
This report aggregates metadata indexed in the Cloudflare D1 database of the CNS Open Data Portal across PubMed, Europe PMC, OpenNeuro, DANDI Archive, Allen Brain Map, Agora, and Zenodo. All ingested records undergo automated disease entity recognition, modality extraction, and license normalization.
Featured Open Datasets & Papers Referenced in This Digest
Allen Brain Atlas: Human Brain ISH Autism Study
High-resolution ISH data detailing gene expression with a unique panel of lamina- and cell type- specific markers to phenotype cortical microstructure during the early years after autism onset.... Freely accessible open data product maintained by the Allen Institute for Brain Science.
Agora Target Validation: INPP5D (inositol polyphosphate-5-phosphatase D) in Alzheimer’s Disease
This gene is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and encodes a protein with an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the...
Agora Target Validation: NRN1 (neuritin 1) in Alzheimer’s Disease
This gene encodes a member of the neuritin family, and is expressed in postmitotic-differentiating neurons of the developmental nervous system and neuronal structures associated with plasticity in the adult. The expression of this gene can be induced by neural activity and neurotrophins. The encoded protein contains a ...
Agora Target Validation: BIN1 (bridging integrator 1) in Alzheimer’s Disease
This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, syna...
Allen Brain Atlas: Multi-plane optical physiology during image change detection
Time series of behavioral variables and neural activity measured with multi-plane in vivo 2-photon imaging in mice performing a visual change detection task where mice were trained with image set A and tested with a novel image set B... Freely accessible open data product maintained by the Allen Institute for Brain Science.
Agora Target Validation: HTRA1 (HtrA serine peptidase 1) in Alzheimer’s Disease
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of ...